PRPO

MKT CAP:$50M

Precipio, Inc.

Market Cap

$50M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$27.03+$3.21 (+13.48%)

Apr 23, 2026

Company Details

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media th...

CEO

Ilan Danieli

IPO Date

Jun 30, 2017

Website

www.precipiodx.com

Key Metrics TTM

Revenue

$24M

+29.8% YoY

Net Income

-$363.0K

EPS (Diluted)

-$0.26

Free Cash Flow

$359.0K

Revenue / Share

$14.98

Gross Margin

44.5%

Operating Margin

-5.0%

Net Margin

-1.5%

FCF Margin

1.5%

P/S

2.1x

P/E

—

Earnings Reports

FY 2025

Mar 30, 2026

$24M+50.6%EPS -$0.23

Q4 2025

Mar 30, 2026

$8M+46.3%EPS $0.33

Q3 2025

Nov 14, 2025

$6M+18.3%EPS -$0.05

Q2 2025

Aug 13, 2025

$6M+27.3%EPS $0.05

Q1 2025

May 14, 2025

$4M+24.0%EPS -$0.59

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$2M	$321.0K	-$5M
Q2 22	$2M	$773.0K	-$2M
Q3 22	$2M	$436.0K	-$3M
Q4 22	$2M	$598.0K	-$2M
Q1 23	$3M	$749.0K	-$3M
Q2 23	$4M	$1M	-$2M
Q3 23	$4M	$2M	-$1M
Q4 23	$4M	$2M	-$854.0K
Q1 24	$3M	$920.0K	-$2M
Q2 24	$4M	$1M	-$1M
Q3 24	$5M	$2M	-$597.0K
Q4 24	$5M	$3M	-$336.0K
Q1 25	$4M	$2M	-$859.0K
Q2 25	$6M	$2M	-$824.0K
Q3 25	$6M	$3M	-$61.0K
Q4 25	$8M	$3M	$542.0K

Valuation

Quarter	P/S	P/E
Q1 22	3.1x	—
Q2 22	2.6x	—
Q3 22	2.0x	—
Q4 22	1.6x	—
Q1 23	1.7x	—
Q2 23	0.9x	—
Q3 23	0.7x	—
Q4 23	0.6x	—
Q1 24	0.6x	—
Q2 24	0.5x	—
Q3 24	0.6x	—
Q4 24	0.5x	—
Q1 25	0.5x	—
Q2 25	0.8x	—
Q3 25	1.3x	—
Q4 25	1.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$2M	-$2M
Q2 22	-$2M	-$2M
Q3 22	-$2M	-$2M
Q4 22	-$2M	-$2M
Q1 23	-$2M	-$2M
Q2 23	-$1M	-$1M
Q3 23	-$896.0K	-$919.0K
Q4 23	$114.0K	$65.0K
Q1 24	-$667.0K	-$667.0K
Q2 24	$500.0K	$430.0K
Q3 24	$41.0K	-$68.0K
Q4 24	$565.0K	$521.0K
Q1 25	-$44.0K	-$182.0K
Q2 25	$353.0K	$294.0K
Q3 25	$10.0K	-$44.0K
Q4 25	$366.0K	$291.0K

Capital Expenditures

Quarter	CapEx
Q1 22	$10.0K
Q2 22	$96.0K
Q3 22	$119.0K
Q4 22	$52.0K
Q1 23	$22.0K
Q2 23	$32.0K
Q3 23	$23.0K
Q4 23	$49.0K
Q1 24	$0
Q2 24	$70.0K
Q3 24	$109.0K
Q4 24	$44.0K
Q1 25	$138.0K
Q2 25	$59.0K
Q3 25	$54.0K
Q4 25	$75.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+34.2%	+83.2%
Q2 22	+0.6%	+7.1%
Q3 22	-1.4%	+16.2%
Q4 22	-1.8%	-11.7%
Q1 23	+15.1%	-19.5%
Q2 23	+49.8%	+21.6%
Q3 23	+68.8%	-4.7%
Q4 23	+81.1%	+9.9%
Q1 24	+21.8%	-5.8%
Q2 24	+25.7%	-3.0%
Q3 24	+39.4%	+12.0%
Q4 24	+25.9%	+11.6%
Q1 25	+24.0%	-7.1%
Q2 25	+27.3%	+14.7%
Q3 25	+18.3%	+7.2%
Q4 25	+46.3%	+28.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$2M	91.2%
Q2 22	$451.0K	19.1%
Q3 22	$722.0K	32.6%
Q4 22	$396.0K	16.6%
Q1 23	$450.0K	16.0%
Q2 23	$352.0K	10.0%
Q3 23	$366.0K	9.8%
Q4 23	$567.0K	13.1%
Q1 24	$357.0K	10.4%
Q2 24	$299.0K	6.7%
Q3 24	$147.0K	2.8%
Q4 24	$823.0K	15.1%
Q1 25	$423.0K	9.9%
Q2 25	$449.0K	7.9%
Q3 25	$232.0K	3.8%
Q4 25	$105.0K	1.3%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	—	—	—	$5M
Q4 22	$3M	$3M	$100.0K	—
Q2 23	—	—	—	$4M
Q3 23	—	—	—	$3M
Q4 23	$3M	$3M	$100.0K	—
Q1 24	—	—	—	$3M
Q2 24	—	—	—	$3M
Q4 24	$2M	$3M	$100.0K	—
Q4 25	—	$789.0K	—	—

Revenue Segments

Quarter	Other	Service revenue, net
Q2 22	$220.0K	$2M
Q3 22	$235.0K	$2M
Q1 23	$761.0K	$2M
Q2 23	$877.0K	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$9M	$0	$9M
Q2 22	$7M	$0	$7M
Q3 22	$5M	$0	$5M
Q4 22	$3M	$0	$3M
Q1 23	$2M	$0	$2M
Q2 23	$3M	$0	$3M
Q3 23	$2M	$0	$2M
Q4 23	$2M	$0	$2M
Q1 24	$776.0K	$0	$776.0K
Q2 24	$1M	$0	$1M
Q3 24	$1M	$0	$1M
Q4 24	$1M	$0	$1M
Q1 25	$1M	$0	$1M
Q2 25	$1M	$0	$1M
Q3 25	$2M	$0	$2M
Q4 25	$6M	$0	$6M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	1M	+0.0%	+27.1%
Q2 22	1M	+0.0%	+7.9%
Q3 22	1M	+0.3%	+0.3%
Q4 22	1M	+0.2%	+0.5%
Q1 23	1M	+1.7%	+2.2%
Q2 23	1M	+5.0%	+7.3%
Q3 23	1M	+14.5%	+22.5%
Q4 23	1M	+1.8%	+24.5%
Q1 24	1M	+0.4%	+22.9%
Q2 24	1M	+2.6%	+20.1%
Q3 24	1M	+1.1%	+6.1%
Q4 24	1M	+0.9%	+5.2%
Q1 25	2M	+0.6%	+5.4%
Q2 25	2M	+6.6%	+9.5%
Q3 25	2M	+2.2%	+10.6%
Q4 25	2M	-2.0%	+7.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$44.5K	55
Q2 22	$42.9K	55
Q3 22	$40.3K	55
Q4 22	$43.5K	55
Q1 23	$51.2K	55
Q2 23	$64.2K	55
Q3 23	$68.0K	55
Q4 23	$84.9K	51
Q1 24	$67.3K	51
Q2 24	$87.1K	51
Q3 24	$102.1K	51
Q4 24	$100.9K	54
Q1 25	$78.8K	54
Q2 25	$104.7K	54
Q3 25	$114.1K	54
Q4 25	$130.7K	61

Revenue / Employee